|
Apresoline-esidrixDrug - Apresoline-esidrix The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Hydralazine Hydrochloride; Hydrochlorothiazide
Strength -
25MG;15MG
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
012026
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Apresoline-esidrix
Hydralazine Hcl W/ Hydrochlorothiazide 25/25 25mg;25mg Capsule; Oral
Hydralazine Hcl W/ Hydrochlorothiazide 50/50 50mg;50mg Capsule; Oral Hydra-zide 100mg;50mg Capsule; Oral Hydra-zide 25mg;25mg Capsule; Oral Hydra-zide 50mg;50mg Capsule; Oral Apresoline-esidrix 25mg;15mg Tablet; Oral Hydralazine Hcl And Hydrochlorothiazide 100mg;50mg Capsule; Oral Hydralazine Hcl And Hydrochlorothiazide 25mg;25mg Capsule; Oral Hydralazine Hcl And Hydrochlorothiazide 50mg;50mg Capsule; Oral Hydralazine Hcl W/ Hydrochlorothiazide 100/50 100mg;50mg Capsule; Oral NewDrugInformation |